These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15037227)

  • 1. Getting more mileage out of a tankful of new molecular entities?
    Cavalla D
    Drug Discov Today; 2004 Apr; 9(7):304-5. PubMed ID: 15037227
    [No Abstract]   [Full Text] [Related]  

  • 2. Peter Corr outlines Pfizer's approach to innovation, maximizing capabilities and delivering essential medicine. Interview by Steve Carney.
    Corr PB
    Drug Discov Today; 2005 Aug; 10(15):1017-20. PubMed ID: 16055016
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug Discovery Technology and Development 2005 - IBC's Tenth World Congress. Emerging and early stage company showcase pre-conference symposium.
    Razvi ES
    IDrugs; 2005 Oct; 8(10):796-8. PubMed ID: 16254794
    [No Abstract]   [Full Text] [Related]  

  • 4. Special issue on CNS experimental medicine.
    Dawson GR; Dourish CT; Goodwin GM
    J Psychopharmacol; 2011 Sep; 25(9):1145-7. PubMed ID: 21994313
    [No Abstract]   [Full Text] [Related]  

  • 5. New developments in neuroscience.
    Williams M
    Curr Opin Investig Drugs; 2003 Jan; 4(1):26-7. PubMed ID: 12625023
    [No Abstract]   [Full Text] [Related]  

  • 6. Central nervous system drug development, basic, and clinical research: thinking outside the box.
    Klein DF; Glick ID; Shader RI
    J Clin Psychopharmacol; 2011 Oct; 31(5):553-4. PubMed ID: 21869701
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular imaging as a de-risking tool: coming into focus?
    Mullard A
    Nat Rev Drug Discov; 2013 Apr; 12(4):251-2. PubMed ID: 23535924
    [No Abstract]   [Full Text] [Related]  

  • 8. Opportunities and challenges in the discovery of new central nervous system drugs.
    Krause JE; Chenard BL
    Ann N Y Acad Sci; 2008 Nov; 1144():243-50. PubMed ID: 19076381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing the discovery organization for innovation.
    Sams-Dodd F
    Drug Discov Today; 2005 Aug; 10(15):1049-56. PubMed ID: 16055021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.
    Fish PV; Wakenhut F; Ryckmans T; Stobie A
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4579-83. PubMed ID: 19616432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass spectrometry analysis of new chemical entities for pharmaceutical discovery.
    Fang AS; Miao X; Tidswell PW; Towle MH; Goetzinger WK; Kyranos JN
    Mass Spectrom Rev; 2008; 27(1):20-34. PubMed ID: 18033735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges in the search for drugs to treat central nervous system disorders.
    Enna SJ; Williams M
    J Pharmacol Exp Ther; 2009 May; 329(2):404-11. PubMed ID: 19182069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of amides of 2,4-dioxothiazolidin-5-yl acetic acid with 1,2,4-triazole substituents.
    Trotsko N; Dobosz M; Chodkowska A; Jagiełło-Wójtowicz E
    Acta Pol Pharm; 2008; 65(2):217-21. PubMed ID: 18666428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of target validation in drug discovery and development.
    Lowe JA; Jones P; Wilson DM
    Curr Opin Drug Discov Devel; 2009 Sep; 12(5):581-4. PubMed ID: 19736617
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis and biological activity of new derivatives of 3-phenoxymethyl-4-R-D2-1,2,4-triazoline-5-thione.
    Jagiełło-Wójtowicz E; Chodkowska A; Pachuta-Stec A; Dobosz M
    Acta Pol Pharm; 2004 Dec; 61 Suppl():11-3. PubMed ID: 15909924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How the biopharmaceutical industry uses molecular imaging.
    Hwang DR; Evelhoch J
    J Nucl Med; 2008 Jun; 49(6):24N-25N. PubMed ID: 18511815
    [No Abstract]   [Full Text] [Related]  

  • 17. [Synthesis of N, N-disubstituted beta-hydroxytryptamines].
    Ge BL; Tan ZY
    Yao Xue Xue Bao; 1982 May; 17(5):385-7. PubMed ID: 7180473
    [No Abstract]   [Full Text] [Related]  

  • 18. Neglected diseases: getting less neglected?
    Senior K
    Drug Discov Today; 2005 Jul; 10(13):878. PubMed ID: 15993802
    [No Abstract]   [Full Text] [Related]  

  • 19. Drugmakers plow more resources into autism.
    Sheridan C
    Nat Biotechnol; 2013 May; 31(5):367-9. PubMed ID: 23657371
    [No Abstract]   [Full Text] [Related]  

  • 20. Optical imaging in drug discovery and diagnostic applications.
    Licha K; Olbrich C
    Adv Drug Deliv Rev; 2005 Jun; 57(8):1087-108. PubMed ID: 15908041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.